FDA lifts clinical hold on Neurizon’s ALS drug

The lifting of the FDA’s clinical hold on Neurizon’s drug will pave the way for its investigation in the HEALEY-ALS trial.
WJAC-TV

Eric Dane told fellow ALS sufferer Aaron Lazar about his diagnosis before going public

Eric Dane opened up to Aaron Lazar about his ALS battle months before he went public with his health crisis, the Broadway ...

I’m 60 and have been diagnosed with a terminal illness that will require constant costly care. How can I set up my retirement accounts to pay for it?

However, there is a caveat: if she accesses this benefit early, she’ll receive quite a bit less in monthly payments. Normally, it’s best to hold off claiming Social Security until 67 or, better yet, ...

Exposure to mining fossil fuel linked to ALS, new research finds

A major pollutant from fossil fuels has been linked to an increased risk of amyotrophic lateral sclerosis (ALS), according to ...
BioSpace

FDA Lifts Clinical Hold, Clearing Neurizon’s ALS Drug for Human Trials

The hold was placed earlier this year when the FDA asked for more preclinical data, but the agency was slow to respond due to ...
ALS News Today

Northwestern researcher is hoping to change how ALS is treated

Northwestern University professor Hande Ozdinler is hoping to change how ALS is treated, saying the disease is too complex ...